Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagy

Background Ischemia-reperfusion (I/R) injury is inevitable during the perioperative period. The pancreas is susceptible to I/R injury. Autophagy, a self-digestion process, is upregulated during I/R injury and strongly induced by hypoxia. This study aims to determine whether dexmedetomidine can decre...

Full description

Saved in:
Bibliographic Details
Main Authors: Jin Ha Park, Ju Eun Oh, Namo Kim, Young-Lan Kwak
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2024-12-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kja-24457.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846136098443493376
author Jin Ha Park
Ju Eun Oh
Namo Kim
Young-Lan Kwak
author_facet Jin Ha Park
Ju Eun Oh
Namo Kim
Young-Lan Kwak
author_sort Jin Ha Park
collection DOAJ
description Background Ischemia-reperfusion (I/R) injury is inevitable during the perioperative period. The pancreas is susceptible to I/R injury. Autophagy, a self-digestion process, is upregulated during I/R injury and strongly induced by hypoxia. This study aims to determine whether dexmedetomidine can decrease pancreatic β-cell damage by regulating autophagy under hypoxia. Methods INS-1 rat insulinoma cells were cultured in dexmedetomidine before being exposed to cobalt chloride (CoCl2)-induced hypoxia. Cell viability and the expression of autophagy-related proteins (light chain 3B [LC3B]-II, p62, and ATGs) were assessed. The expression of apoptosis-related proteins (BCL-2 and P-BAD) were also evaluated. CoCl2-treated INS-1 cells were pretreated with the autophagosome formation inhibitor, 3-methyladenine (3-MA), to compare its effects with those of dexmedetomidine. Bafilomycin-A1 (Baf-A1) that inhibits autophagosome degradation was used to confirm the changes in autophagosome formation induced by dexmedetomidine. Results Dexmedetomidine attenuated the increased expression of autophagic proteins (LC3B-II, p62, and ATGs) and reversed the CoCl2-induced reduction in the proliferation of INS-1 cells after hypoxia. Dexmedetomidine also alleviated the decreased expression of the anti-apoptotic protein (BCL-2) and the increased expression of apoptotic protein (BAX). Dexmedetomidine reduces the activation of autophagy through inhibiting autophagosome formation, as confirmed by a decrease in LC3B-II/I ratio, a marker of autophagosome formation, in LC3B turnover assay combined with Baf-A1. Conclusions Dexmedetomidine alleviates the degree of cellular damage in INS-1 cells against CoCl2-induced hypoxia by regulating autophagosome formation. These results provide a basis for further studies to confirm these effects in clinical practice.
format Article
id doaj-art-473e7d3d04f14fafb66f1dec997fcee4
institution Kabale University
issn 2005-6419
2005-7563
language English
publishDate 2024-12-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj-art-473e7d3d04f14fafb66f1dec997fcee42024-12-09T08:30:35ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632024-12-0177662363410.4097/kja.244579010Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagyJin Ha Park0Ju Eun Oh1Namo Kim2Young-Lan Kwak3 Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, KoreaBackground Ischemia-reperfusion (I/R) injury is inevitable during the perioperative period. The pancreas is susceptible to I/R injury. Autophagy, a self-digestion process, is upregulated during I/R injury and strongly induced by hypoxia. This study aims to determine whether dexmedetomidine can decrease pancreatic β-cell damage by regulating autophagy under hypoxia. Methods INS-1 rat insulinoma cells were cultured in dexmedetomidine before being exposed to cobalt chloride (CoCl2)-induced hypoxia. Cell viability and the expression of autophagy-related proteins (light chain 3B [LC3B]-II, p62, and ATGs) were assessed. The expression of apoptosis-related proteins (BCL-2 and P-BAD) were also evaluated. CoCl2-treated INS-1 cells were pretreated with the autophagosome formation inhibitor, 3-methyladenine (3-MA), to compare its effects with those of dexmedetomidine. Bafilomycin-A1 (Baf-A1) that inhibits autophagosome degradation was used to confirm the changes in autophagosome formation induced by dexmedetomidine. Results Dexmedetomidine attenuated the increased expression of autophagic proteins (LC3B-II, p62, and ATGs) and reversed the CoCl2-induced reduction in the proliferation of INS-1 cells after hypoxia. Dexmedetomidine also alleviated the decreased expression of the anti-apoptotic protein (BCL-2) and the increased expression of apoptotic protein (BAX). Dexmedetomidine reduces the activation of autophagy through inhibiting autophagosome formation, as confirmed by a decrease in LC3B-II/I ratio, a marker of autophagosome formation, in LC3B turnover assay combined with Baf-A1. Conclusions Dexmedetomidine alleviates the degree of cellular damage in INS-1 cells against CoCl2-induced hypoxia by regulating autophagosome formation. These results provide a basis for further studies to confirm these effects in clinical practice.http://ekja.org/upload/pdf/kja-24457.pdfautophagybeta cellscell injurycobalt chloridedexmedetomidinehypoxiapancreasrat
spellingShingle Jin Ha Park
Ju Eun Oh
Namo Kim
Young-Lan Kwak
Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagy
Korean Journal of Anesthesiology
autophagy
beta cells
cell injury
cobalt chloride
dexmedetomidine
hypoxia
pancreas
rat
title Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagy
title_full Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagy
title_fullStr Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagy
title_full_unstemmed Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagy
title_short Dexmedetomidine alleviates CoCl-induced hypoxic cellular damage in INS-1 cells by regulating autophagy
title_sort dexmedetomidine alleviates cocl induced hypoxic cellular damage in ins 1 cells by regulating autophagy
topic autophagy
beta cells
cell injury
cobalt chloride
dexmedetomidine
hypoxia
pancreas
rat
url http://ekja.org/upload/pdf/kja-24457.pdf
work_keys_str_mv AT jinhapark dexmedetomidinealleviatescoclinducedhypoxiccellulardamageinins1cellsbyregulatingautophagy
AT jueunoh dexmedetomidinealleviatescoclinducedhypoxiccellulardamageinins1cellsbyregulatingautophagy
AT namokim dexmedetomidinealleviatescoclinducedhypoxiccellulardamageinins1cellsbyregulatingautophagy
AT younglankwak dexmedetomidinealleviatescoclinducedhypoxiccellulardamageinins1cellsbyregulatingautophagy